News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Operations

Latest News

April 4th 2025
Pharmaceutical Industry Avoids Trump’s Tariffs — For Now
By PharmExec Staff

Eli Lilly CEO David Ricks to the BBC: “It feels like it'll be hard to come back from here."

March 24th 2025

Biogen to Establish New Global HQ and Innovation Hub in Massachusetts by 2028

By Don Tracy, Associate Editor
March 21st 2025

Johnson & Johnson to Invest Over $55 Billion in US Manufacturing Facilities

By Don Tracy, Associate Editor
March 7th 2025

DB-OTO and the Evolving Approach to Genetic Deafness in Children

By Don Tracy, Associate Editor
Advertisement

Advertisement
  • Prev
  • 1
  • 2
  • Prev
Advertisement
Advertisement

Trending on PharmExec

1

FDA Appoints Tracy Beth Høeg as Acting Director of CDER

2

Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion

3

Five Steps for Successful CGT Commercialization Through Health Systems Partnerships

4

FDA Approves Expanded Indication of Jaypirca for Adults with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

5

FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us